10-Q: A SPAC III Acquisition Corp. Reports Net Income of $413,202 for Q1 2025
Quarterly Report
A SPAC III Acquisition Corp. reports a net income of $413,202 for the quarter ended March 31, 2025, driven by interest income from its trust account.
Summary
- A SPAC III Acquisition Corp., a blank check company, reported its financial results for the quarter ended March 31, 2025.
- The company achieved a net income of $413,202, primarily due to interest income of $647,080 from investments held in the trust account.
- General and administrative expenses totaled $233,878 for the quarter.
- As of March 31, 2025, the company had cash of $1,119,610 and investments held in the trust account totaling $60,988,996.
- The company is pursuing a business combination and has signed non-binding agreements with HD Group and Bioserica International Limited.
- The company has until November 12, 2025, to complete a business combination, raising concerns about its ability to continue as a going concern.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the company reports a net income, it's primarily from interest income, and there are concerns about the ability to complete a business combination and continue as a going concern.
Positives
- The company generated a net income of $413,202 for the quarter, indicating effective management of its trust account.
- The company secured $647,080 in interest income from its trust account.
- The company has signed non-binding agreements with HD Group and Bioserica International Limited, indicating progress towards a business combination.
Negatives
- The company's general and administrative expenses totaled $233,878, reducing overall profitability.
- The company's ability to continue as a going concern is in doubt if a business combination is not completed by November 12, 2025.
Risks
- The company's ability to consummate a Business Combination may be materially and adversely affected by various social and political circumstances in the U.S. and around the world.
- The company's ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by increased market volatility, or decreased market liquidity.
- The company may need to obtain additional financing either to complete its Business Combination or because it becomes obligated to redeem a significant number of public shares upon consummation of its Business Combination.
- If the Company is unable to complete its Business Combination because it does not have sufficient funds available, it will may cease operations and liquidate the Trust Account.
- The company's ability to continue as a going concern is in doubt if a business combination is not completed by November 12, 2025.
Future Outlook
The company intends to complete a business combination, but there is no assurance that it will be successful. The company has until November 12, 2025, to complete a business combination, raising concerns about its ability to continue as a going concern.
Management Comments
- Management has determined that if the Company is unable to complete a Business Combination by November 12, 2025 (assuming no extension), then the Company will cease all operations except for the purpose of liquidating.
- The date for liquidation and subsequent dissolution as well as liquidity concerns raise substantial doubt about the Company's ability to continue as a going concern.
Industry Context
This announcement is typical for SPACs, which are formed to raise capital through an IPO for the purpose of acquiring an existing company. The financial results reflect the SPAC's pre-acquisition phase, where income is primarily derived from interest earned on the trust account.
Comparison to Industry Standards
- SPACs typically hold the IPO proceeds in a trust account, investing in low-risk assets like U.S. government treasury bills or money market funds.
- The interest income generated from the trust account is a common source of revenue for SPACs before they complete a business combination.
- The general and administrative expenses are also typical for SPACs, covering costs related to maintaining the company's public listing and searching for a target company.
- The timeline for completing a business combination is usually 12-24 months, and the risk of liquidation if a deal is not completed within that timeframe is a standard risk for SPAC investors.
- Comparable companies include other SPACs listed on exchanges like Nasdaq and NYSE, such as Gores Metropoulos II, Inc. and Churchill Capital Corp VII, which follow similar financial reporting patterns before their respective acquisitions.
Related Party Transactions
- The Sponsor purchased private placement units at a price of $10.00 per unit for an aggregate purchase price of $2,800,000.
- The Sponsor has agreed to loan the Company up to $350,000 to be used for a portion of the expenses of the IPO.
- The Company subsequently repaid the $276,221 outstanding balance under the Promissory Note on January 24, 2025.
Stakeholder Impact
- Shareholders face the risk of liquidation if a business combination is not completed by November 12, 2025.
- Employees are impacted by the uncertainty surrounding the company's future and potential liquidation.
- The target companies (HD Group and Bioserica International Limited) are impacted by the uncertainty of the business combination.
Next Steps
- The company intends to continue searching for and completing a business combination.
- The company needs to execute definitive agreements with HD Group and Bioserica International Limited or identify alternative targets.
- The company must complete a business combination by November 12, 2025, to avoid liquidation.
Key Dates
| Date | Description |
|---|---|
| 2021-09-03 | Company incorporated as a British Virgin Islands business company. |
| 2024-07-23 | Company issued and repurchased Class B ordinary shares from the Sponsor. |
| 2024-11-08 | Registration statement for the Company's IPO was declared effective. |
| 2024-11-12 | Company consummated its IPO of 5,500,000 units and private placement of 280,000 units to the Sponsor. |
| 2024-11-15 | Underwriters notified the Company of their election to partially exercise the over-allotment option. |
| 2024-11-19 | Closing of the issuance and sale of the additional Units occurred and the company consummated the private sale of an additional 5,000 Private Placement Units to the Sponsor. |
| 2024-12-31 | Company entered into an agreement with HDEducation Group Limited. |
| 2025-01-24 | Company entered into an agreement with Bioserica International Limited and repaid the Promissory Note in full. |
| 2025-03-31 | End of the financial reporting period for this 10-Q filing. |
| 2025-05-09 | Date of the report. |
| 2025-11-12 | Deadline for completing the initial Business Combination (assuming no extension). |
Keywords
business combination, SPAC, acquisition, trust account, ESG, IPO, financial statements
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.